Billings SD, Brenn T, Hornick JL (2018) Cutaneous angiosarcoma. In: Elder DE, Massi D, Scolyer RA, Willemze R et al (eds) World Health Organization Classification of Skin Tumours. IARC Press, Lyon, France, pp 335–336

Google Scholar 

Thomas K, Billing SD. Angiosarcoma (2020) In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, 5th ed. Lyon, France: IARC Press, pp 176–178

Young RJ, Brown NJ, Reed MW et al (2010) Angiosarcoma. Lancet Oncol 11:983–991. https://doi.org/10.1016/S1470-2045(10)70023-1

Article  PubMed  Google Scholar 

Deyrup AT, McKenney JK, Tighiouart M et al (2008) Sporadic Cutaneous Angiosarcomas: A Proposal for Risk Stratification Based on 69 Cases. Am J Surg Pathol 32:72–77. https://doi.org/10.1097/PAS.0b013e3180f633a3

Article  PubMed  Google Scholar 

Dettenborn T, Wermker K, Schulze HJ et al (2014) Prognostic features in angiosarcoma of the head and neck: a retrospective monocenter study. J Craniomaxillofac Surg 42:1623–1628. https://doi.org/10.1016/j.jcms.2014.05.002

Pollock RE, Maki RG (2017) Introduction of soft tissue sarcoma. In: Amin MB, Edge SB, Greene FL, et al. eds. AJCC Cancer Staging Manual, 8th ed. Chicago, U.S.A.: SPRINGER-VERLAG, pp 489–497

Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, Aozasa K (1996) Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 61:170–176. https://doi.org/10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8

Sinnamon AJ, Neuwirth MG, McMillan MT et al (2016) A prognostic model for resectable soft tissue and cutaneous angiosarcoma. J Surg Oncol 114:557–563. https://doi.org/10.1002/jso.24352

Shon W, Jenkins SM, Ross DT et al (2011) Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness. J Cutan Pathol 38:961–966. https://doi.org/10.1111/j.1600-0560.2011.01790.x

Buehler D, Rush P, Hasenstein JR (2013) Expression of Angiopoietin-TIE System Components in Angiosarcoma. Mod Pathol 26:1032–1040. https://doi.org/10.1038/modpathol.2013.43

Article  CAS  PubMed  PubMed Central  Google Scholar 

Motaparthi K, Lauer SR, Patel RM et al (2020) MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria. J Cutan Pathol 1–9. https://doi.org/10.1111/cup.13912

Jiromaru R, Yamamoto H, Yasumatsu R et al (2020) HPV-related Sinonasal Carcinoma: Clinicopathologic Features, Diagnostic Utility of p16 and Rb Immunohistochemistry, and EGFR Copy Number Alteration. Am J Surg Pathol 44:305–315. https://doi.org/10.1097/PAS.0000000000001410

Article  PubMed  Google Scholar 

Italiano A, Chen CL, Thomas R et al (2012) Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer 118:5878–5887. https://doi.org/10.1002/cncr.27614

Article  CAS  PubMed  Google Scholar 

Ginter PS, Mosquera JM, MacDonald TY et al (2014) Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites. Hum Pathol 45:709–716. https://doi.org/10.1016/j.humpath.2013.11.002

Article  CAS  PubMed  Google Scholar 

Brierly JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumors. Wiley-Blackwell, pp 124–126

Murali R, Chandramohan R, Möller I et al (2015) Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway. Oncotarget 6:36041–36052. https://doi.org/10.18632/oncotarget.5936

Article  PubMed  PubMed Central  Google Scholar 

Shimozono N, Jinnin M, Masuzawa M et al (2015) NUP160–SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma. Cancer Res 75:4458–44565. https://doi.org/10.1158/0008-5472.CAN-15-0418

Painter CA, Jain E, Tomson BN et al (2020) The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med 26:181–187. https://doi.org/10.1038/s41591-019-0749-z

Article  CAS  PubMed  Google Scholar 

Giatromanolaki A, Kouroupi M, Balaska K, Koukourakis MI (2020) Immunohistochemical detection of senescence markers in human sarcomas. Pathol Res Pract 216(2):152800. https://doi.org/10.1016/j.prp.2019.152800

Article  CAS  PubMed  Google Scholar 

Baruah P, Lee M, Wilson PO et al (2015) Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers. Br J Cancer 113(4):653–659. https://doi.org/10.1038/bjc.2015.251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Lu A, Li L, Yue J, Lu Y (2010) p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells. Cancer Invest 28(6):588–597. https://doi.org/10.3109/07357900903286941

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eelen G, Treps L, Li X, Carmeliet P (2020) Basic and Therapeutic Aspects of Angiogenesis Updated. Circ Res 127(2):310–329. https://doi.org/10.1161/CIRCRESAHA.120.316851

Article  CAS  PubMed  Google Scholar 

Shon W, Sukov WR, Jenkins SM, Folpe AL (2014) MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study. Mod Pathol 27:509–515. https://doi.org/10.1038/modpathol.2013.163

Udager AM, Ishikawa MK, Lucas DR et al (2016) MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience. Pathology 48:697–704. https://doi.org/10.1016/j.pathol.2016.08.007

Article  CAS  PubMed  Google Scholar 

Machado I, Giner F, Lavernia J et al (2021) Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis. Histol Histopathol 36:3–18. https://doi.org/10.14670/HH-18-246

Article  CAS  PubMed  Google Scholar 

Donnell RM, Rosen PP, Lieberman PH et al (1981) Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 5:629–642

Article  CAS  PubMed  Google Scholar 

Antonescu C (2014) Malignant vascular tumors–an update. Mod Pathol 27:S30-38. https://doi.org/10.1038/modpathol.2013.176

Article  CAS  PubMed  Google Scholar 

Kuba MG, Dermawan JK, Xu B et al (2023) Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of Breast: Proposal of a Simplified 2-tier Grading System. Am J Surg Pathol 47(3):303–317. https://doi.org/10.1097/PAS.0000000000001998

Article  Google Scholar